|

DXC014 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Hangzhou DAC Biotechnology Co., Ltd.1

Indications

  • Other Advanced Solid Tumors1
  • Melanoma1
  • Prostate Cancer1
  • Small Cell Lung Cancer1
  • Lung Cancer1

Other1 trial

A Study of DXC014 in Patients With Advanced Solid Tumors.
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.